Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

EE403 Health and Economic Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in Germany: A Cost-Effectiveness Analysis

S. Talbird,J. Graham, S. Anderson,M. Nossov,N. Beattie,Lains C. Sousa, A. Rak, H. Masters,F. Diaz-Mitoma

Value in health（2022）

Cited 0|Views7
No score
Abstract
The novel 3-antigen hepatitis B vaccine was granted marketing authorization by the European Commission in April 2022. This analysis estimates the cost-effectiveness of the 3-antigen vaccine relative to the single-antigen vaccine to prevent hepatitis B virus (HBV) infection among adults in Germany.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined